Literature DB >> 10705159

Cure from severe aplastic anemia in vivo and late effects.

G Socié1, E Gluckman.   

Abstract

Recent progress in the treatment of aplastic anemia has dramatically changed the previously grim prognosis for these patients. Improvements in bone marrow transplantation and immunosuppression have increased the number of long-term survivors so that immediate survival is no longer the sole concern. Here, were review the major clinical studies and summarize recent analyses of late malignant and nonmalignant complications following treatment of aplastic anemia. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10705159     DOI: 10.1159/000041004

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

Review 1.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

2.  Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

Authors:  David Buchbinder; Diane J Nugent; Ruta Brazauskas; Zhiwei Wang; Mahmoud D Aljurf; Mitchell S Cairo; Robert Chow; Christine Duncan; Lamis K Eldjerou; Vikas Gupta; Gregory A Hale; Joerg Halter; Brandon M Hayes-Lattin; Jack W Hsu; David A Jacobsohn; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Paulette Mehta; Kasiani C Myers; Susan K Parsons; Jakob R Passweg; Joseph Pidala; Vijay Reddy; Carmen M Sales-Bonfim; Bipin N Savani; Adriana Seber; Mohamed L Sorror; Amir Steinberg; William A Wood; Donna A Wall; Jacek H Winiarski; Lolie C Yu; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.